The Inbound Trade Mission delivers opportunities for foreign health-tech businesses to enter the UK market. We at GIANT Health still remain committed to finding new business opportunities for overseas companies outside of the U.K. We still want to encourage and support global healthcare technology and innovation.
If you are interested and would still like to find out more please contact us, we would love to hear from you.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…